Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06516042 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

StatusActive, Not Recruiting
PhasePhase 3
SponsorPATH
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Dec 31, 2024 to Jan 24, 2025
    • Study completion date: Dec 31, 2024 to Jul 2025
    • Site details revised
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 29, 2024 to Aug 21, 2024
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
PATH
7 trials monitored
See all monitored trials
The purpose of the study is to assess the effectiveness, feasibility, and acceptability of targeted drug administration for seasonal migrant populations in Metema District, Amhara Region, Ethiopia
Trial Details
NCT Number NCT06516042
Lead Sponsor PATH
Collaborators: Federal Minstry of Health of Ethiopia
Conditions
(from sponsor)		 Plasmodium Falciparum, Malaria
Related terms Malaria, Malaria, Falciparum
Enrollment 10,350 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov